For the hypertension studies, the following table presents adverse reactions more common on diltiazem than on placebo but excluding events with no plausible relationship to treatment, as reported in placebo controlled hypertension trials in patients receiving a diltiazem hydrochloride extended release formulation once a day dosing up to 540 mg medicamento priligy estudios clinicos